Markets rally after Trump announces tariff deal with Japan

Global financial markets rallied after the US and Japan reached a trade deal, reducing threatened tariffs on Japanese goods from 25% to 15%, which, while still above the previous baseline, alleviated immediate uncertainty. This agreement spurred significant gains in Japanese equities, notably carmakers like Toyota (+14%), and boosted European markets, with the FTSE 100 hitting a record high. Investors view this as a potential blueprint for future trade negotiations with the EU, fostering optimism, yet analysts caution that the new tariff levels remain higher than pre-Trump rates, posing long-term inflationary risks despite short-term market relief.

Analysis

A US-Japan trade agreement has catalyzed a significant global equity rally by reducing a threatened 25% tariff on Japanese goods to a new rate of 15%. This development provided substantial relief to markets, evidenced by a 3.5% surge in the Nikkei index and a notable 14% jump in Toyota's shares. The optimism was widespread, with the FTSE 100 reaching a record high and EU automakers like Volkswagen rising over 5% on speculation that this deal could serve as a blueprint for upcoming negotiations with the EU. However, this short-term euphoria, driven by the resolution of immediate uncertainty, masks a more challenging long-term reality. The new 15% tariff remains above the previous 10% baseline, signaling a net increase in trade friction that could fuel inflationary pressures for US consumers and disrupt supply chains. As noted by economists, if this becomes the standard for future deals, it may contribute to a gradual deterioration of the macroeconomic backdrop rather than a true normalization of trade relations.

Key Decisions for Investors

• While the immediate relief rally in Japanese and European automotive stocks is significant, investors should closely monitor the upcoming US-EU trade negotiations, as the 15% tariff set with Japan may become the new, more costly, benchmark for the sector.
• The establishment of a higher tariff baseline introduces a persistent inflationary risk; therefore, portfolios should be reviewed for sensitivity to rising US consumer prices and potential margin compression for companies reliant on global supply chains.
• Given the market's preference for certainty, traders might anticipate similar short-term positive reactions ahead of the August negotiation deadlines with the EU and China, but long-term investors should remain cautious about the negative macroeconomic impact of permanently higher trade costs.
• For UK-listed companies with high US exposure like GSK, AstraZeneca, and Diageo, the deal reduces tail risk and reinforces a more stable outlook, potentially justifying holding or accumulating positions.